Ovid Therapeutics Inc.
Organization details
- Legal name
- Ovid Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OVID
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001636651
- EIN
- 46-5270895
Board of directors
-
Anna Greka · DirectorSince 2026
-
Barbara Gayle Duncan · DirectorSince 2023
-
Bart Friedman · DirectorSince 2023
-
Jeremy M. Levin · Director · Executive ChairmanSince 2023
-
Karen Bernstein · DirectorSince 2023
-
Kevin Joseph Fitzgerald · DirectorSince 2023
-
Margaret A. Alexander · Director · President and CEOSince 2026
-
Robert Michael Poole · DirectorSince 2023
-
Stelios Papadopoulos · DirectorSince 2025
Chief executives
Director election results
Annual meeting of July 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
75.6%
-
83.9%
Board connections
2 of this board's directors also sit on 3 other boards. 3 are in the same sector.
-
Atea Pharmaceuticals Inc. Same sectorvia Barbara Gayle Duncan
-
Exelixis Inc. Same sectorvia Stelios Papadopoulos
-
Halozyme Therapeutics Inc. Same sectorvia Barbara Gayle Duncan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $29,286
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 6, 2026 | Carter Charles Ross Officer (Chief Financial Officer) | Grant or award | +50,000 | — | — |
| Apr 7, 2026 | Stelios Papadopoulos Director | Grant or award | +17,578 | $2.56 | $45,000 |
| Apr 7, 2026 | Bart Friedman Director | Grant or award | +8,789 | $2.56 | $22,500 |
| Apr 7, 2026 | Kevin Joseph Fitzgerald Director | Grant or award | +17,578 | $2.56 | $45,000 |
| Mar 23, 2026 | Jeremy M. Levin Director, Officer (Executive Chairman) | Option exercise | +47,333 | $1.40 | $66,266 |
| Feb 26, 2026 | Rona Jeffrey A Officer (CBFO) | Grant or award | +68,125 | — | — |
| Feb 23, 2026 | Rona Jeffrey A Officer (CBFO) | Open-market sale | −8,541 | $1.45 | $12,384 |
| Feb 23, 2026 | Margaret A. Alexander Director, Officer (President and CEO) | Open-market sale | −11,656 | $1.45 | $16,901 |
| Dec 15, 2025 | Jeremy M. Levin Director, Officer (CEO) | Derivative conversion | +71,000 | — | — |
| Dec 8, 2025 | Takeda Pharmaceuticals U.S.A., Inc. 10% owner | Derivative conversion | +1,250,000 | — | — |
| Feb 26, 2025 | ALEXANDER MARGARET A. Officer (President and COO) | Open-market sale | −5,279 | $0.56 | $2,956 |
| Feb 26, 2025 | Rona Jeffrey A Officer (CBFO) | Open-market sale | −3,902 | $0.56 | $2,185 |
| Feb 20, 2025 | Rona Jeffrey A Officer (CBFO) | Grant or award | +43,750 | — | — |
| Feb 20, 2025 | ALEXANDER MARGARET A. Officer (President and COO) | Grant or award | +43,750 | — | — |
| Jan 27, 2025 | ALEXANDER MARGARET A. Officer (President and COO) | Open-market purchase | +6,810 | $0.73 | $4,971 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Ovid Therapeutics Inc.
Who is the CEO of Ovid Therapeutics Inc.?
Jeremy M. Levin is Ovid Therapeutics Inc.'s CEO.
How many directors are on Ovid Therapeutics Inc.'s board?
Ovid Therapeutics Inc.'s board has 9 directors: Anna Greka, Barbara Gayle Duncan, Bart Friedman, Jeremy M. Levin, Karen Bernstein, Kevin Joseph Fitzgerald, Margaret A. Alexander, Robert Michael Poole and Stelios Papadopoulos.
Are Ovid Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Ovid Therapeutics Inc. insiders made no open-market purchases and sold $29,286 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="ovid-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.